<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.ukri.org:80/organisation/83D87776-5958-42AE-889D-B8AECF16B468"><gtr:id>83D87776-5958-42AE-889D-B8AECF16B468</gtr:id><gtr:name>University of Leeds</gtr:name><gtr:address><gtr:line1>University of Leeds</gtr:line1><gtr:line4>Leeds</gtr:line4><gtr:line5>West Yorkshire</gtr:line5><gtr:postCode>LS2 9JT</gtr:postCode><gtr:region>Yorkshire and The Humber</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/78778E97-5A2E-40A6-A88F-137A343A3530"><gtr:id>78778E97-5A2E-40A6-A88F-137A343A3530</gtr:id><gtr:name>University of Toronto</gtr:name></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/AB7C0822-BBCB-4C61-85EC-5D13C7A31759"><gtr:id>AB7C0822-BBCB-4C61-85EC-5D13C7A31759</gtr:id><gtr:name>MRC Laboratory of Molecular Biology</gtr:name><gtr:address><gtr:line1>Hills Road</gtr:line1><gtr:line4>Cambridge</gtr:line4><gtr:postCode>CB2 2QH</gtr:postCode><gtr:region>East of England</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/AB7C0822-BBCB-4C61-85EC-5D13C7A31759"><gtr:id>AB7C0822-BBCB-4C61-85EC-5D13C7A31759</gtr:id><gtr:name>MRC Laboratory of Molecular Biology</gtr:name><gtr:address><gtr:line1>Hills Road</gtr:line1><gtr:line4>Cambridge</gtr:line4><gtr:postCode>CB2 2QH</gtr:postCode><gtr:region>East of England</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/83D87776-5958-42AE-889D-B8AECF16B468"><gtr:id>83D87776-5958-42AE-889D-B8AECF16B468</gtr:id><gtr:name>University of Leeds</gtr:name><gtr:address><gtr:line1>University of Leeds</gtr:line1><gtr:line4>Leeds</gtr:line4><gtr:line5>West Yorkshire</gtr:line5><gtr:postCode>LS2 9JT</gtr:postCode><gtr:region>Yorkshire and The Humber</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/78778E97-5A2E-40A6-A88F-137A343A3530"><gtr:id>78778E97-5A2E-40A6-A88F-137A343A3530</gtr:id><gtr:name>University of Toronto</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/415F9E79-1641-4793-99E6-05652012FE61"><gtr:id>415F9E79-1641-4793-99E6-05652012FE61</gtr:id><gtr:firstName>Alan</gtr:firstName><gtr:otherNames>J</gtr:otherNames><gtr:surname>Warren</gtr:surname><gtr:orcidId>0000-0001-9277-4553</gtr:orcidId><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=MC_U105161083"><gtr:id>A12859D2-AD0D-4090-8231-D5C94FD0CABF</gtr:id><gtr:title>Molecular mechanisms of eukaryotic ribosome biogenesis</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Intramural</gtr:grantCategory><gtr:grantReference>MC_U105161083</gtr:grantReference><gtr:abstractText>Human leukaemias are a significant cause of morbidity and mortality in children and adults. However, we have little understanding of the molecular basis of the multistep progression to leukaemia. A major goal of our studies is to identify and characterise the function of new molecules that participate in the development of these cancers of the blood. We further aim to determine the three-dimensional shape of the molecules involved in order to facilitate the development of novel targeted approaches to therapy.</gtr:abstractText><gtr:technicalSummary>Ribosome assembly is an essential, highly conserved process that is tightly coupled to cell growth and proliferation. However, the molecular mechanisms underlying this process remain poorly understood. Excitingly, a new class of cancer predisposition syndromes collectively called the ?ribosomopathies? has recently emerged that harbour mutations in components of the ribosome assembly pathway. In particular, we have discovered that the SBDS protein that is deficient in the leukaemia predisposition disorder Shwachman-Diamond syndrome is required for maturation of the large ribosomal subunit. SBDS controls the translational activation of ribosomes by catalysing dissociation of the anti-association factor eIF6 from nascent 60S subunits, but the precise mechanism remains unclear. We propose a model in which GTP-dependent conformational change in elongation factor-like 1 (EFL1) triggers an inter-domain rotation in SBDS that directly or indirectly triggers eIF6 release. We aim to test this hypothesis at the molecular level by combining the latest advances in single-particle cryo-electron microscopy and NMR spectroscopy with X-ray crystallography, biochemistry and innovative genetic platforms. We will test the hypothesis that eIF6 release is a prerequisite for eviction of additional assembly factors whose specific role in ribosome assembly we will determine. Finally, we will apply state-of-the-art genetic approaches to identify additional components of the pathway. Novel insights into the mechanisms of ribosome assembly are exploitable not only for the design of targeted therapeutics for the ribosomopathies, but also for cancer drug discovery more generally. 
To facilitate translation of this work to direct clinical care, we have initiated collaborations with paediatric haematologists in the UK and in Europe. We will participate in tissue banking to facilitate prospective studies through the Haematology Department at Addenbrookes Hospital in accordance with National and Local ethical guidelines.</gtr:technicalSummary><gtr:fund><gtr:end>2013-03-31</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2000-04-01</gtr:start><gtr:type>EXPENDITURE_ACTUAL</gtr:type><gtr:valuePounds>2709823</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Leeds</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>Characterization of RNA aptamers to AML1</gtr:description><gtr:id>9E483A85-6FDB-4FA4-8284-504F7DC438FF</gtr:id><gtr:impact>Barton JL, Bunka DH, Knowling SE, Lefevre P, Warren AJ, Bonifer C, Stockley PG. Characterization of RNA aptamers that disrupt the RUNX1-CBFbeta/DNA complex. Nucleic Acids Res. (2009) 37:6818-30. Epub 2009 Sep 9.</gtr:impact><gtr:outcomeId>fqh1spS1zc4-1</gtr:outcomeId><gtr:piContribution>Purification of protein complexes</gtr:piContribution><gtr:sector>Academic/University</gtr:sector></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Toronto</gtr:collaboratingOrganisation><gtr:country>Canada</gtr:country><gtr:description>Charles Boone, University of Toronto</gtr:description><gtr:id>FB1CA670-680A-4050-80AA-9F8F37E3A5C3</gtr:id><gtr:impact>Publication PubMed ID: 17353896</gtr:impact><gtr:outcomeId>AB029913DD9-1</gtr:outcomeId><gtr:partnerContribution>Publication PubMed ID: 17353896</gtr:partnerContribution><gtr:piContribution>Together with the Boone Laboratory, we identified the function of the yeast homologue of the SBDS gene mutated in Shwachman-Diamond syndrome using biochemical and genetic approaches in yeast</gtr:piContribution><gtr:sector>Academic/University</gtr:sector></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>Invited talk</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>8E4F3FBB-9ED9-4255-806B-8AE3AE1604F1</gtr:id><gtr:impact>American Society of Hematology, Orlando, Florida Mixed international audience of scientists and professional Haematologists

Publication of research findings in the journal Nature Genetics 2007. Subsequent productive collaborations and interactions with other investigators in the field, successful Programme funding application to the Leukaemia Research Fund</gtr:impact><gtr:outcomeId>77829C3FD05</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:primaryAudience>Other academic audiences (collaborators, peers etc.)</gtr:primaryAudience><gtr:year>2006</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>162000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>AICR Project Grant</gtr:description><gtr:end>2011-03-02</gtr:end><gtr:fundingOrg>Association for International Cancer Research (AICR)</gtr:fundingOrg><gtr:id>07D17BDA-F33A-413F-A86F-2BFD5395ADC2</gtr:id><gtr:outcomeId>1B0BBA944AD0</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2008-04-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>75000</gtr:amountPounds><gtr:country>United States of America</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Leukaemia Society of America</gtr:description><gtr:end>2011-03-02</gtr:end><gtr:fundingOrg>The Leukemia &amp; Lymphoma Society</gtr:fundingOrg><gtr:id>4242E0DF-E0A9-455F-9C8B-2B7942277529</gtr:id><gtr:outcomeId>84348A4075A0</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2006-03-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>100000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Tesni Parry Memorial Fund</gtr:description><gtr:end>2013-03-02</gtr:end><gtr:fundingOrg>University of Cambridge</gtr:fundingOrg><gtr:id>30B501B5-C5D8-4143-B20C-D4F938611433</gtr:id><gtr:outcomeId>mHA57VXezzf0</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2011-04-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs/><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>595E1AFE-2C6D-40F8-9A0E-A0323CB8C4C7</gtr:id><gtr:title>A p53-dependent mechanism underlies macrocytic anemia in a mouse model of human 5q- syndrome.</gtr:title><gtr:parentPublicationTitle>Nature medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/63ff2ec91e39761c3b838f4287d94b6e"><gtr:id>63ff2ec91e39761c3b838f4287d94b6e</gtr:id><gtr:otherNames>Barlow JL</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1078-8956</gtr:issn><gtr:outcomeId>E12DE27ECED</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>16EDEC4B-F4DA-497B-80E6-18261D52A4E6</gtr:id><gtr:title>Uncoupling of GTP hydrolysis from eIF6 release on the ribosome causes Shwachman-Diamond syndrome.</gtr:title><gtr:parentPublicationTitle>Genes &amp; development</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/443614f23ce67da889848c1567a59920"><gtr:id>443614f23ce67da889848c1567a59920</gtr:id><gtr:otherNames>Finch AJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0890-9369</gtr:issn><gtr:outcomeId>a2ZMe2pvWnC</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8944CC96-652A-4C57-820F-E8860DB49AA7</gtr:id><gtr:title>Structural consequences of nucleophosmin mutations in acute myeloid leukemia.</gtr:title><gtr:parentPublicationTitle>The Journal of biological chemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f4ef8b043311bbc4370efe77c4be38e7"><gtr:id>f4ef8b043311bbc4370efe77c4be38e7</gtr:id><gtr:otherNames>Grummitt CG</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0021-9258</gtr:issn><gtr:outcomeId>3A688B46A82</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6742531D-D8B7-4B05-9C1E-2285587CB711</gtr:id><gtr:title>Somatic SF3B1 mutation in myelodysplasia with ring sideroblasts.</gtr:title><gtr:parentPublicationTitle>The New England journal of medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c4c954d767ba92727eabc85d0b700988"><gtr:id>c4c954d767ba92727eabc85d0b700988</gtr:id><gtr:otherNames>Papaemmanuil E</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0028-4793</gtr:issn><gtr:outcomeId>kcjorYVwMm9</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>26C608B3-F6E3-4A29-9396-6CB86B36DE98</gtr:id><gtr:title>Characterization of RNA aptamers that disrupt the RUNX1-CBFbeta/DNA complex.</gtr:title><gtr:parentPublicationTitle>Nucleic acids research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/02718fd80984945ba46f4cb4f6bac939"><gtr:id>02718fd80984945ba46f4cb4f6bac939</gtr:id><gtr:otherNames>Barton JL</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0305-1048</gtr:issn><gtr:outcomeId>F797857BD97</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>13E2410F-B415-4670-BEB6-AB7B11B910E8</gtr:id><gtr:title>Shwachman-Bodian-Diamond syndrome (SBDS) protein deficiency impairs translation re-initiation from C/EBPa and C/EBP? mRNAs.</gtr:title><gtr:parentPublicationTitle>Nucleic acids research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8c07676d30083786c312a215caf037d6"><gtr:id>8c07676d30083786c312a215caf037d6</gtr:id><gtr:otherNames>In K</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0305-1048</gtr:issn><gtr:outcomeId>56d08327c7a566.30181691</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C849118D-74BB-4093-A009-98AEB69CCD8E</gtr:id><gtr:title>JAK2 exon 12 mutations in polycythemia vera and idiopathic erythrocytosis.</gtr:title><gtr:parentPublicationTitle>The New England journal of medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2f38166e91e8d35a4a97e905f37b13e9"><gtr:id>2f38166e91e8d35a4a97e905f37b13e9</gtr:id><gtr:otherNames>Scott LM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0028-4793</gtr:issn><gtr:outcomeId>6192C9CC824</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F528E467-6FE2-4C19-8CC8-E2837DC685C2</gtr:id><gtr:title>New insights into 5q- syndrome as a ribosomopathy.</gtr:title><gtr:parentPublicationTitle>Cell cycle (Georgetown, Tex.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/63ff2ec91e39761c3b838f4287d94b6e"><gtr:id>63ff2ec91e39761c3b838f4287d94b6e</gtr:id><gtr:otherNames>Barlow JL</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1551-4005</gtr:issn><gtr:outcomeId>WfeEZ86Yj5q</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>4AB50F14-C9F3-43C9-BEFD-799E21802335</gtr:id><gtr:title>Defective ribosome assembly in Shwachman-Diamond syndrome.</gtr:title><gtr:parentPublicationTitle>Blood</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/4852dac52ef4a5c5435bb9c375a03bff"><gtr:id>4852dac52ef4a5c5435bb9c375a03bff</gtr:id><gtr:otherNames>Wong CC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0006-4971</gtr:issn><gtr:outcomeId>UbWY1xuH129</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F6EDCC2F-FAF1-419B-9FD0-A6FFFFA04CFF</gtr:id><gtr:title>Solution structure of the nonmethyl-CpG-binding CXXC domain of the leukaemia-associated MLL histone methyltransferase.</gtr:title><gtr:parentPublicationTitle>The EMBO journal</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/61de41cef5e0acf82cff59ae4b6ce3a3"><gtr:id>61de41cef5e0acf82cff59ae4b6ce3a3</gtr:id><gtr:otherNames>Allen MD</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>0261-4189</gtr:issn><gtr:outcomeId>EA4C906B25C</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2C849765-AF80-46B3-A135-18873BDC57E5</gtr:id><gtr:title>The mechanism of repression of the myeloid-specific c-fms gene by Pax5 during B lineage restriction.</gtr:title><gtr:parentPublicationTitle>The EMBO journal</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a0d2881cc26fca8234af9c32378992ba"><gtr:id>a0d2881cc26fca8234af9c32378992ba</gtr:id><gtr:otherNames>Tagoh H</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>0261-4189</gtr:issn><gtr:outcomeId>72F7267A954</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>DCDBCF25-8CF5-442B-B288-71617B1CBF31</gtr:id><gtr:title>Development and validation of a comprehensive genomic diagnostic tool for myeloid malignancies.</gtr:title><gtr:parentPublicationTitle>Blood</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/46876f4e7c662ddb25c33f54fe22f57d"><gtr:id>46876f4e7c662ddb25c33f54fe22f57d</gtr:id><gtr:otherNames>McKerrell T</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0006-4971</gtr:issn><gtr:outcomeId>585d6b2f865ba1.02465445</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C6BE9E5B-47E6-4F5C-8A19-8D5ECD784EF3</gtr:id><gtr:title>Mechanism of eIF6 release from the nascent 60S ribosomal subunit.</gtr:title><gtr:parentPublicationTitle>Nature structural &amp; molecular biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5aa4a10057d5e31aa761e4feb9adc665"><gtr:id>5aa4a10057d5e31aa761e4feb9adc665</gtr:id><gtr:otherNames>Weis F</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1545-9985</gtr:issn><gtr:outcomeId>563a43736b2578.28471598</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>99B5328D-3ACE-4C00-833E-4B85CA3B6C24</gtr:id><gtr:title>The Shwachman-Bodian-Diamond syndrome protein mediates translational activation of ribosomes in yeast.</gtr:title><gtr:parentPublicationTitle>Nature genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/7f4cb51b14908cb45fe2354b698e6861"><gtr:id>7f4cb51b14908cb45fe2354b698e6861</gtr:id><gtr:otherNames>Menne TF</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>1061-4036</gtr:issn><gtr:outcomeId>25CB4190D92</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D4BC53AD-B726-400E-8D0B-1692382ECEC8</gtr:id><gtr:title>The Ribosome Biogenesis Protein Nol9 Is Essential for Definitive Hematopoiesis and Pancreas Morphogenesis in Zebrafish.</gtr:title><gtr:parentPublicationTitle>PLoS genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2070899bdb913e4773c2e6617fa222dc"><gtr:id>2070899bdb913e4773c2e6617fa222dc</gtr:id><gtr:otherNames>Bielczyk-Maczynska E</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1553-7390</gtr:issn><gtr:outcomeId>56d0832784a730.22244141</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">MC_U105161083</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>7C58A707-1BF6-4573-A44F-30B271C80813</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Cancer</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>1BF330A9-C7B5-49C5-B54B-CF4FAE6DF1D8</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>2.1  Biological and endogenous factors</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>